ARGX-110

· OncoVerity, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ARGX-110, covering 2023-08-09 to 2023-08-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS) [Phase 1, Phase 2]

See pricing